(er)
Need an official quote in your mailbox?
Our automated system will send you a quote for your specific qty along with Discount, timelines and Stock status.
08:0 Lyso PC
PHOSPHOLIPIDS
| CAT No.# | CS-CC-00014 |
| Category | Phospholipids |
| CAS | 45287-18-1 |
| Stock Status |
AVAILABLE
Do you want a quotation or have a question about '08:0 Lyso PC' ? We normally respond within 2 hours.Do you want a quotation or have a question about '08:0 Lyso PC' ? We normally respond within 2 hours.(Available within 3-5 days) Product maybe under re-certification or re-stock. Enquire now to know exact date of delivery and pricing. |
| Molecular Weight | 383.42 |
| Molecular Formula | C16H34NO7P |
| Synonyms: | (S)-1-hydroxy-3-(octanoyloxy)propan-2-yl (2-(trimethylammonio)ethyl) phosphate |
| References: | Stafford, R.E., Fanni, T., Dennis, E.A. (1989) Interfacial properties and critical micelle concentration of lysophospholipids. Biochemistry. 28(12):5113-20. |
| Shipping: | Free Shipping for worldwide on order above 2000 USD |
Product rating: 9 08:0 Lyso PC based on 20 ratings
PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Riluzole (1604337)
15. Pheniramine impurity B
16. Palbociclib N-Glucuronide
17. Carpropamid
18. Olmesartan N1-Trityl Impurity
19. Aripiprazole (1042634)
20. 2-(p-Tolyl)pyrimidine
This page contains information about 08:0 Lyso PC Cas 45287-18-1 and its Phospholipids.
08:0 Lyso PC 08:0 Lyso PC Worldwide Suppliers of 08:0 Lyso PC https://www.clearsynth.com/en/CSCC00014.html Phospholipids Clearsynth 45287-18-1
"Products currently covered by valid US Patents
are offered for R&D use in accordance with 35 USC 271(e)+A13(1).
Any patent infringement and resulting liability is solely at
buyer risk."